EPA-Approved SARS-CoV-2 Disinfectants
5 rows where Active_ingredient contains "Chlorine dioxide" and Use_site contains "Residential" sorted by ID descending
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Contact_time, Formulation_type, Date_on_List_N, Why_on_List_N,
Active_ingredient (array)
✖
ID ▲
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time
|
Formulation_type
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
2227 |
88341-11 |
Increased Risk |
Chlorine dioxide |
Pure 100 |
T.A. Comb, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
10.0 minutes |
Ready-to-use |
Feline Calicivirus |
2021-11-23 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1325 |
87492-1 |
Increased Risk |
Chlorine dioxide |
Electro-Biocide |
Strategic Resource Optimization Inc |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
10.0 minutes |
Ready-to-use |
Rhinovirus |
2020-04-23 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1194 |
82972-1 |
Increased Risk |
Chlorine dioxide; Quaternary ammonium |
Vital Oxide |
Vital Solutions LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
5.0 minutes |
Ready-to-use |
SARS-CoV-2 |
2021-09-28 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1166 |
71700-2 |
Increased Risk |
Chlorine dioxide; Quaternary ammonium |
SNiPER |
Global Environmental Restoration Inc |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
10.0 minutes |
Ready-to-use |
Canine parvovirus |
2020-04-09 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1034 |
98223-1 |
Increased Risk |
Chlorine dioxide |
Pro Oxide |
Environmental Suface Solutions |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
10.0 minutes |
Dilutable |
Canine parvovirus |
2020-11-05 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |